-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of 1-(3-bromophenylsulfonyl)piperidine is a complex and multi-step process that involves various chemical reactions and purification steps.
This article will provide a detailed overview of the production process of 1-(3-bromophenylsulfonyl)piperidine, which is also commonly known as Isoflurane.
Isoflurane is a halogenated compound that is commonly used as an inhalation anesthetic in the medical field.
It is a colorless gas that has a mild, sweet odor, and it is highly soluble in water.
The production process of Isoflurane involves several steps, which are outlined below:
Step 1: Preparation of the starting material
The production of Isoflurane begins with the preparation of the starting material, which is 3-bromophenyl sulfide.
This compound is synthesized by reacting phenyl chloride with sodium sulfide in the presence of a solvent such as acetonitrile.
The resulting compound is then purified by precipitation with sodium hydroxide and filtration.
Step 2: Williamson ether synthesis
The next step in the production process of Isoflurane is the Williamson ether synthesis, which involves the condensation of 3-bromophenyl sulfide with piperidine in the presence of a Lewis acid catalyst such as aluminum chloride.
This reaction is carried out in a solvent such as dichloromethane, and the resulting mixture is then purified by filtration and chromatography.
Step 3: Hydrolysis of the Williamson ether
The next step in the production process of Isoflurane is the hydrolysis of the Williamson ether, which involves the decomposition of the Williamson ether using water and a strong acid catalyst such as hydrochloric acid.
This step is necessary to remove the protecting group from the nitrogen atom of the piperidine ring.
Step 4: Dehydrobromination
The next step in the production process of Isoflurane is the dehydrobromination of the resulting compound, which involves the removal of the bromine atom from the piperidine ring.
This step is carried out by reacting the compound with a reducing agent such as lithium aluminum hydride in the presence of a solvent such as tetrahydrofuran.
The resulting mixture is then purified by filtration and chromatography.
Step 5: Nitration
The final step in the production process of Isoflurane is the nitration of the compound, which involves the introduction of a nitro group onto the piperidine ring.
This step is carried out by reacting the compound with nitric acid in the presence of a solvent such as acetonitrile.
The resulting mixture is then purified by filtration and chromatography.
Purification and characterization
After completing the production process, the resulting compound is purified by several techniques, including filtration, centrifugation, and chromatography.
The purified compound is then characterized by various analytical techniques such as spectroscopy, mass spectrometry, and chromatography.
These techniques are used to confirm the identity and purity of the compound.
Conclusion
The production process of Isoflurane involves several steps that require careful control of the reaction conditions and purification of the resulting compound.
The purified compound is then characterized to ensure its identity and purity.
The final product is a pure and stable compound that is used as an inhalation anesthetic in the medical field.